| Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila JS Steffan, L Bodai, J Pallos, M Poelman, A McCampbell, BL Apostol, ... Nature 413 (6857), 739-743, 2001 | 1485 | 2001 |
| Expression and function of Toll‐like receptors 2 and 4 in human keratinocytes A Pivarcsi, L Bodai, B Réthi, A Kenderessy‐Szabó, A Koreck, M Széll, ... International immunology 15 (6), 721-730, 2003 | 494 | 2003 |
| Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes I Nagy, A Pivarcsi, K Kis, A Koreck, L Bodai, A McDowell, H Seltmann, ... Microbes and infection 8 (8), 2195-2205, 2006 | 469 | 2006 |
| Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington’s disease J Pallos, L Bodai, T Lukacsovich, JM Purcell, JS Steffan, LM Thompson, ... Human molecular genetics 17 (23), 3767-3775, 2008 | 326 | 2008 |
| Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance R Spohn, L Daruka, V Lázár, A Martins, F Vidovics, G Grézal, O Méhi, ... Nature communications 10 (1), 4538, 2019 | 295 | 2019 |
| ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease P Maher, R Dargusch, L Bodai, PE Gerard, JM Purcell, JL Marsh Human molecular genetics 20 (2), 261-270, 2011 | 269 | 2011 |
| A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila BL Apostol, A Kazantsev, S Raffioni, K Illes, J Pallos, L Bodai, N Slepko, ... Proceedings of the National Academy of Sciences 100 (10), 5950-5955, 2003 | 225 | 2003 |
| Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila N Agrawal, J Pallos, N Slepko, BL Apostol, L Bodai, LW Chang, ... Proceedings of the National Academy of Sciences 102 (10), 3777-3781, 2005 | 207 | 2005 |
| Targeting H3K4 trimethylation in Huntington disease M Vashishtha, CW Ng, F Yildirim, TA Gipson, IH Kratter, L Bodai, W Song, ... Proceedings of the National Academy of Sciences 110 (32), E3027-E3036, 2013 | 190 | 2013 |
| Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity BL Apostol, K Illes, J Pallos, L Bodai, J Wu, A Strand, ES Schweitzer, ... Human molecular genetics 15 (2), 273-285, 2006 | 174 | 2006 |
| Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis AI Koreck, Z Csoma, L Bodai, F Ignacz, AS Kenderessy, E Kadocsa, ... Journal of allergy and clinical immunology 115 (3), 541-547, 2005 | 147 | 2005 |
| The homologous Drosophila transcriptional adaptors ADA2a and ADA2b are both required for normal development but have different functions T Pankotai, O Komonyi, L Bodai, Z Ujfaludi, S Muratoglu, A Ciurciu, L Tora, ... Molecular and cellular biology, 2005 | 100 | 2005 |
| Treatment of atopic dermatitis with the xenon chloride excimer laser E Baltas, Z Csoma, L Bodai, F Ignacz, A Dobozy, L Kemény Journal of the European Academy of Dermatology and Venereology 20 (6), 657-660, 2006 | 78 | 2006 |
| Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion A Dunai, R Spohn, Z Farkas, V Lazar, Á Györkei, G Apjok, G Boross, ... Elife 8, e47088, 2019 | 77 | 2019 |
| Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes A Pivarcsi, A Koreck, L Bodai, M Széll, C Szeg, N Belső, ... Archives of dermatological research 296, 120-124, 2004 | 74 | 2004 |
| Analysis of Drosophila melanogaster testis transcriptome V Vedelek, L Bodai, G Grézal, B Kovács, IM Boros, B Laurinyecz, R Sinka BMC genomics 19, 1-19, 2018 | 72 | 2018 |
| Core–shell nanoparticles suppress metastasis and modify the tumour-supportive activity of cancer-associated fibroblasts D Kovács, N Igaz, A Marton, A Rónavári, P Bélteky, L Bodai, G Spengler, ... Journal of nanobiotechnology 18, 1-20, 2020 | 60 | 2020 |
| A novel target for Huntington's disease: ERK at the crossroads of signaling: The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates … L Bodai, JL Marsh Bioessays 34 (2), 142-148, 2012 | 47 | 2012 |
| Endogenous phospholipid metabolite containing topical product inhibits ultraviolet light-induced inflammation and DNA damage in human skin L Kemény, A Koreck, K Kis, A Kenderessy-Szabo, L Bodai, A Cimpean, ... Skin pharmacology and physiology 20 (3), 155-161, 2007 | 43 | 2007 |
| Intranasal irradiation with the xenon chloride ultraviolet B laser improves allergic rhinitis Z Csoma, F Ignacz, Z Bor, G Szabo, L Bodai, A Dobozy, L Kemeny Journal of Photochemistry and Photobiology B: Biology 75 (3), 137-144, 2004 | 42 | 2004 |
J. Lawrence MarshVerified email at uci.edu